Proof based on human and animal studies revealed that dysregulation of chemerin may serve as a risk indicator for hyperglycemia, vascular inflammation, angiogenesis, atherosclerosis, chronic heart failure and blood pressure modulation [190]. This evidence concerns the gene RARRES2 and atherosclerosis.